Crystalline salt forms of antifolate compounds and methods of manufacturing thereof

Details for Australian Patent Application No. 2009233829 (hide)

Owner Chelsea Therapeutics, Inc.

Inventors Horvath, Karol; Pimplaskar, Harish K.; Lebedev, Mikhail

Agent Fisher Adams Kelly

Pub. Number AU-A-2009233829

PCT Pub. Number WO2009/126639

Priority 61/042,998 07.04.08 US; 61/042,994 07.04.08 US

Filing date 7 April 2009

Wipo publication date 15 October 2009

International Classifications

C07D 239/95 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/126639 Priority application(s): WO2009/126639

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009233836-Air blown asphalt including polyphosphoric acid

2009233826-Apparatus and method for analysis of a fluid sample